1. Home
  2. AKRO vs CHEF Comparison

AKRO vs CHEF Comparison

Compare AKRO & CHEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKRO
  • CHEF
  • Stock Information
  • Founded
  • AKRO 2017
  • CHEF 1985
  • Country
  • AKRO United States
  • CHEF United States
  • Employees
  • AKRO N/A
  • CHEF N/A
  • Industry
  • AKRO Biotechnology: Pharmaceutical Preparations
  • CHEF Food Distributors
  • Sector
  • AKRO Health Care
  • CHEF Consumer Discretionary
  • Exchange
  • AKRO Nasdaq
  • CHEF Nasdaq
  • Market Cap
  • AKRO 1.8B
  • CHEF 2.2B
  • IPO Year
  • AKRO 2019
  • CHEF 2011
  • Fundamental
  • Price
  • AKRO $51.84
  • CHEF $63.39
  • Analyst Decision
  • AKRO Strong Buy
  • CHEF Strong Buy
  • Analyst Count
  • AKRO 9
  • CHEF 6
  • Target Price
  • AKRO $75.86
  • CHEF $66.00
  • AVG Volume (30 Days)
  • AKRO 2.2M
  • CHEF 597.7K
  • Earning Date
  • AKRO 03-03-2025
  • CHEF 02-12-2025
  • Dividend Yield
  • AKRO N/A
  • CHEF N/A
  • EPS Growth
  • AKRO N/A
  • CHEF 50.69
  • EPS
  • AKRO N/A
  • CHEF 1.32
  • Revenue
  • AKRO N/A
  • CHEF $3,794,212,000.00
  • Revenue This Year
  • AKRO N/A
  • CHEF $7.80
  • Revenue Next Year
  • AKRO N/A
  • CHEF $7.33
  • P/E Ratio
  • AKRO N/A
  • CHEF $49.19
  • Revenue Growth
  • AKRO N/A
  • CHEF 10.50
  • 52 Week Low
  • AKRO $17.86
  • CHEF $31.96
  • 52 Week High
  • AKRO $58.40
  • CHEF $66.51
  • Technical
  • Relative Strength Index (RSI)
  • AKRO 65.39
  • CHEF 69.78
  • Support Level
  • AKRO $48.70
  • CHEF $64.69
  • Resistance Level
  • AKRO $51.40
  • CHEF $66.51
  • Average True Range (ATR)
  • AKRO 2.29
  • CHEF 2.26
  • MACD
  • AKRO -0.90
  • CHEF 0.71
  • Stochastic Oscillator
  • AKRO 35.50
  • CHEF 78.01

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.

About CHEF The Chefs' Warehouse Inc.

The Chefs' Warehouse Inc is a specialty food distributor in metropolitan areas across the United States and Canada. The company's product portfolio is comprised of imported and local specialty food products such as cheese, cooking oils, chocolates, dried food, baking products, meats, and other food products. The Chefs' Warehouse operates via one reporting segment called Food Product Distribution. Operations are concentrated on the east, mid and west coasts of the U.S. The company provides service to restaurants, clubs, hotels, caterers, schools, bakeries, casinos and speciality food stores.

Share on Social Networks: